Moors & Cabot’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.87M | Buy |
62,233
+1,008
| +2% | +$81.3K | 0.19% | 106 |
|
|
2026
Q1 | $5.31M | Buy |
61,225
+6,494
| +12% | +$622K | 0.23% | 94 |
|
|
2025
Q4 | $5.26M | Sell |
54,731
-121
| -0.2% | -$11.8K | 0.23% | 90 |
|
|
2025
Q3 | $5.22M | Sell |
54,852
-4,504
| -8% | -$414K | 0.23% | 88 |
|
|
2025
Q2 | $5.17M | Sell |
59,356
-2,178
| -4% | -$185K | 0.24% | 85 |
|
|
2025
Q1 | $5.53M | Sell |
61,534
-4,947
| -7% | -$443K | 0.28% | 74 |
|
|
2024
Q4 | $5.31M | Buy |
66,481
+1,220
| +2% | +$106K | 0.25% | 81 |
|
|
2024
Q3 | $5.88M | Sell |
65,261
-1,211
| -2% | -$102K | 0.29% | 73 |
|
|
2024
Q2 | $5.23M | Buy |
66,472
+4,183
| +7% | +$343K | 0.28% | 79 |
|
|
2024
Q1 | $5.43M | Sell |
62,289
-16,687
| -21% | -$1.42M | 0.29% | 74 |
|
|
2023
Q4 | $6.51M | Sell |
78,976
-6,925
| -8% | -$528K | 0.41% | 49 |
|
|
2023
Q3 | $6.73M | Buy |
85,901
+1,217
| +1% | +$102K | 0.46% | 41 |
|
|
2023
Q2 | $7.46M | Buy |
84,684
+3,326
| +4% | +$286K | 0.5% | 41 |
|
|
2023
Q1 | $6.56M | Buy |
81,358
+3,680
| +5% | +$300K | 0.45% | 43 |
|
|
2022
Q4 | $6.04M | Buy |
77,678
+7,622
| +11% | +$618K | 0.42% | 48 |
|
|
2022
Q3 | $5.66M | Buy |
70,056
+79
| +0.1% | +$7.1K | 0.43% | 48 |
|
|
2022
Q2 | $6.28M | Buy |
69,977
+2,636
| +4% | +$267K | 0.45% | 46 |
|
|
2022
Q1 | $7.47M | Buy |
67,341
+5,678
| +9% | +$600K | 0.46% | 46 |
|
|
2021
Q4 | $6.38M | Buy |
61,663
+3,961
| +7% | +$459K | 0.39% | 56 |
|
|
2021
Q3 | $7.23M | Buy |
57,702
+4,043
| +8% | +$523K | 0.45% | 44 |
|
|
2021
Q2 | $6.66M | Sell |
53,659
-56
| -0.1% | -$7.03K | 0.47% | 46 |
|
|
2021
Q1 | $6.36M | Sell |
53,715
-144
| -0.3% | -$16.9K | 0.49% | 47 |
|
|
2020
Q4 | $6.31M | Sell |
53,859
-552
| -1% | -$60.8K | 0.53% | 40 |
|
|
2020
Q3 | $5.66M | Sell |
54,411
-330
| -0.6% | -$33.1K | 0.53% | 43 |
|
|
2020
Q2 | $5.02M | Buy |
54,741
+7,780
| +17% | +$746K | 0.53% | 45 |
|
|
2020
Q1 | $4.24M | Buy |
46,961
+87
| +0.2% | +$9.26K | 0.62% | 35 |
|
|
2019
Q4 | $5.31M | Buy |
46,874
+978
| +2% | +$107K | 0.53% | 42 |
|
|
2019
Q3 | $4.99M | Buy |
45,896
+7,799
| +20% | +$814K | 0.55% | 43 |
|
|
2019
Q2 | $3.71M | Sell |
38,097
-1,029
| -3% | -$94K | 0.47% | 53 |
|
|
2019
Q1 | $3.57M | Buy |
39,126
+8,527
| +28% | +$763K | 0.49% | 52 |
|
|
2018
Q4 | $2.78M | Sell |
30,599
-1,380
| -4% | -$129K | 0.44% | 61 |
|
|
2018
Q3 | $3.15M | Sell |
31,979
-14,347
| -31% | -$1.33M | 0.39% | 66 |
|
|
2018
Q2 | $3.97M | Sell |
46,326
-717
| -2% | -$59.9K | 0.53% | 43 |
|
|
2018
Q1 | $3.77M | Sell |
47,043
-471
| -1% | -$38.9K | 0.5% | 45 |
|
|
2017
Q4 | $3.82M | Sell |
47,514
-126
| -0.3% | -$10.1K | 0.51% | 45 |
|
|
2017
Q3 | $3.72M | Buy |
47,640
+4,413
| +10% | +$366K | 0.54% | 42 |
|
|
2017
Q2 | $3.84M | Buy |
43,227
+178
| +0.4% | +$15K | 0.64% | 27 |
|
|
2017
Q1 | $3.45M | Sell |
43,049
-4,668
| -10% | -$365K | 0.58% | 37 |
|
|
2016
Q4 | $3.39M | Buy |
47,717
+1,285
| +3% | +$101K | 0.56% | 40 |
|
|
2016
Q3 | $4.01M | Buy |
46,432
+1,976
| +4% | +$172K | 0.67% | 30 |
|
|
2016
Q2 | $3.85M | Buy |
44,456
+3,694
| +9% | +$299K | 0.68% | 28 |
|
|
2016
Q1 | $3.07M | Sell |
40,762
-398
| -1% | -$30K | 0.55% | 38 |
|
|
2015
Q4 | $3.16M | Buy |
41,160
+30
| +0.1% | +$2.26K | 0.58% | 32 |
|
|
2015
Q3 | $2.74M | Buy |
41,130
+1,314
| +3% | +$96.8K | 0.51% | 45 |
|
|
2015
Q2 | $2.96M | Sell |
39,816
-2,730
| -6% | -$209K | 0.48% | 52 |
|
|
2015
Q1 | $3.33M | Buy |
42,546
+1,791
| +4% | +$136K | 0.55% | 44 |
|
|
2014
Q4 | $2.93M | Sell |
40,755
-1,100
| -3% | -$76.4K | 0.5% | 50 |
|
|
2014
Q3 | $2.59M | Sell |
41,855
-742
| -2% | -$47.2K | 0.44% | 55 |
|
|
2014
Q2 | $2.73M | Buy |
42,597
+6,346
| +18% | +$386K | 0.46% | 53 |
|
|
2014
Q1 | $2.23M | Buy |
+36,251
| New | +$2.11M | 0.56% | 47 |
|
Other funds holding MDT
Moors & Cabot's MDT Position: Q2 2026 in Review
Moors & Cabot increased its Medtronic (MDT) stake by 1.6% in Q2 2026, buying an estimated $81.3K and bringing the position to 62,233 shares worth $4.87M. The position accounts for 0.19% of the portfolio, ranked #106.
Moors & Cabot first reported a position in MDT in Q1 2014 and has held it in 50 quarters since. The position peaked at $7.47M in Q1 2022. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Moors & Cabot held 62,233 shares of Medtronic worth $4.87M as of Q2 2026.
- Moors & Cabot bought 1,008 Medtronic shares in Q2 2026, an estimated $81.3K.
- Medtronic made up 0.19% of Moors & Cabot's portfolio in Q2 2026, its #106 holding.
- Moors & Cabot first reported a position in Medtronic in Q1 2014 and has held it in 50 quarters since.
- Moors & Cabot's Medtronic position peaked at $7.47M in Q1 2022.
- 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Moors & Cabot's 13F filing for Q2 2026, filed 10 Aug 2026.